Company: ZVRA
Filing Date: 2025-03-31
Form Type: PREC14A
Source: 0001193125-25-068746
Chunk: 77

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: PREC14A
Chunk 77
---
 Trail, Suite 103, Boca Raton, Florida 33431                             |
| Corey Watton       |     | President and Chief Executive Officer of Fusion Medical Staffing, LLC                                               |     | 18881 W Dodge Rd, Suite 300W, Elkhorn, Nebraska 68022                                       |
| Thomas D. Anderson |     | Retired                                                                                                             |     | N/A                                                                                         |
| Alvin Shih, M.D.   |     | Chief Executive Officer of Catamaran Bio, Inc.                                                                      |     | Catamaran Bio, 451 D St, 5th Floor Boston, MA 02210                                         |

A-1

Executive Officers and Employees The principal occupations of the Company’s executive officers and employees who are considered “participants” in the Board’s solicitation of proxies (other than our President and Chief Executive Officer, who also serves as a director of the Company) are set forth below. The principal occupation refers to such person’s position with the Company and the business address for each person below is c/o Zevra Therapeutics, Inc., 1180 Celebration Boulevard, Suite 103, Celebration, Florida 34747.

| Name                         |     | Principal Occupation                                  |
| R. LaDuane Clifton, MBA, CPA |     | Chief Financial Officer and Treasurer                 |
| Adrian Quartel, M.D., FFPM   |     | Chief Medical Officer                                 |
| Joshua Schafer, M.S., MBA    |     | Chief Commercial Officer                              |
| Rahsaan W. Thompson          |     | Chief Legal Officer, Secretary and Compliance Officer |

Information Regarding Ownership of Zevra Securities by Participants The number of shares of the Company’s common stock beneficially owned by its directors (including our director nominees) and executive officers that are considered to be participants as of the Record Date is set forth under the “Security Ownership of Certain Beneficial Owners and Management” table and notes thereto elsewhere in this proxy statement.The number of shares held directly by the executive officers and employees and those considered to be associates of participants that are not individually named in the “Security Ownership of Certain Beneficial Owners and Management” table and notes thereto in this proxy statement are shown below:

| Name                      |     | Shares Beneficially Owned |     | Shares Owned of Record But Not Beneficially |
| Joshua Schafer, M.S., MBA |     |                   179,486 |     | N/A                                         |

A-2

Information Regarding Transactions in Zevra Securities by Participants